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Glomerular filtration rate is a predictor of
mortality after endovascular abdominal aortic
aneurysm repair
Ali Azizzadeh, MD,a Luis A. Sanchez, MD,b Charles C. Miller, III, PhD,a Leopoldo Marine, MD,b Brian
G. Rubin, MD,b Hazim J. Safi, MD,a Tam T. Huynh, MD,a Juan C. Parodi, MD,b and Gregorio A.
Sicard, MD,b Houston, Tex; and St Louis, Mo
Objective: Clinically evident renal disease is a risk factor for mortality after aneurysm repair. Serum creatinine is widely
used as a measure of renal function in the preoperative evaluation of patients. Unfortunately, serum creatinine
concentration is influenced by muscle mass, hydration status, and glomerular filtration rate (GFR). Calculated GFR,
which takes predictors of muscle mass such as age, gender, and weight into account, is a more sensitive determinant of
renal function than serum creatinine. We hypothesized that GFR would more accurately predict mortality after EVAR
than serum creatinine.
Methods: We retrospectively evaluated our database of 398 patients who underwent EVAR with the AneuRx device
between October 1999 and October 2004. There were 340 men and 58 women with a mean age of 73. GFR was
calculated using the Cockcroft-Gault equation. The patients were divided into four quartiles by preoperative GFR: I (7
to 45), II (45 to 60), III (61 to 79), and IV (>80). Survival was estimated with the Kaplan-Meier method, and
heterogeneity of mortality across strata was evaluated using the log-rank test. The GFR quartiles were compared with
clinically accepted criteria for abnormal renal function (serum creatinine level >1.7).
Results: Actuarial survival at 48 months was 61.5%, 70.5%, 86.0%, and 85.7% for GFR quartiles I to IV, respectively (P
< .003). Thirty-day mortality was 2.2% in quartile I, 3.2% in quartile II, and 0 in quartiles III and IV (P  .03 for q1 
q2 vs q3 q4, P< .02 for q2 vs q3 q4). Survival curves for quartiles II to IV were statistically indistinguishable, with
quartile II running tangential to the two higher quartiles after the perioperative period. Quartile I fared significantly
worse than the other three quartiles for the entire follow-up period (P < .005). According to American Kidney
Foundation criteria (GFR <90), 83.3% of patients had abnormal renal function compared with 16.1% with abnormal
serum creatinine (>1.7) (P < .0002).
Conclusion: The risk of perioperative and long-term mortality in patients undergoing EVAR is more accurately stratified
by using calculated GFR than serum creatinine alone. A GFR <45 is associated with decreased survival after EVAR.
Perioperative mortality at a GFR of 45 to 60 is comparable with that of the lower quartile (GFR <45), but late survival
is comparable with that of patients with GFR >60. The finding of increased risk of early mortality in patients in the 45
to 60 GFR range, with survivors enjoying good long-term outcome, suggests that these patients may most benefit from
the use of alternative contrast agents and periprocedural renal protection techniques. ( J Vasc Surg 2006;43:14-8.)Preoperative renal dysfunction is a risk factor for
mortality after aneurysm repair.1-4 Accurate identifica-
tion of preoperative risk factors allows clinicians to de-
velop alternative treatment strategies, provide better in-
formed consent, and assess outcome and quality of care.
Traditionally, serum creatinine has been used as a preop-
erative measure of renal function. Although creatinine is
a specific marker for renal function, it may be insensitive
to mild and moderate degrees of renal impairment,
because it depends on predictors of muscle mass such as
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14age, gender, and body weight. As a result, patients with
subclinical renal disease may go undiagnosed because of
a normal serum creatinine value.
According to the National Kidney Foundation guide-
lines, estimates of glomerular filtration rate (GFR) are the
best overall indices of renal function.5 An index that ac-
counts for predictors of muscle mass in addition to serum
creatinine is a more sensitive determinant of renal function.
GFR is most commonly estimated using the Cockcroft-
Gault6 equation, which calculates creatinine clearance from
serum creatinine, age, gender, and body weight. We hy-
pothesized that GFRwould be a more accurate predictor of
mortality after endovascular abdominal aortic aneurysm
repair (EVAR) than serum creatinine.
METHODS
Between October 1999 and October 2004, we per-
formed 398 EVAR procedures using the AneuRx device
(Medtronic, Santa Rosa, Calif) in 340 men and 58 women
(mean age, 73 years). All patients undergoing endovascular
aortoiliac aneurysm repair at our institution are prospec-
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comparison of their outcomes. These patients and their
associated data were reviewed under a Health Insurance
Portability and Accountability Act-compliant protocol ap-
proved by the Washington University Human Studies
Committee. For the purpose of this publication, the review
of the database was supplemented with a retrospective
review of medical records.
Glomerular filtration rate was calculated using the
Cockcroft-Gault equation: Creatinine clearance (mL/min)
 (140–age/years)  (body weight/kg)/72  serum
creatinine (mg/dL)  (0.85 if female).
Twenty patients were excluded because of incomplete
data. The preoperative serum creatinine was used for this
calculation. Preoperative GFR was used to divide the pa-
tients into four quartiles: I (7 to 45), II (46 to 60), III (61
to 79), IV (80).
Descriptive statistics for the cohort were computed by
using standardmeasures of frequency and central tendency.
Survival outcome was evaluated with logistic regression and
contingency table approaches at 30 days and along a 60-
month distribution of failure times by using Kaplan-Meier
and Cox proportional hazards regression.
For univariate analysis, categoric variables were ana-
lyzed by contingency table, and continuous variables were
divided into quartiles for contingency table and stratified
survival analysis. Continuous variables were also left in their
continuous distributions for univariate logistic regression
and Cox regression analyses.
For the 30-day analysis, serum creatinine was dichoto-
mized at 1.7, which is a standard clinical criterion for an
abnormal value at our institution for men aged 69 years
old. No 30-day deaths were present in the upper two
quartiles of GFR, so we dichotomized GFR at the median.
None of the continuous risk factors departed grossly from
normality. Multivariable analyses were conducted by using
logistic regression and Cox regression. All computations
were performed with SAS software version 8.2 (SAS Inc,
Cary, NC).
RESULTS
Actuarial survival at 48 months for GFR quartiles I to
IV was 61.5%, 70.5%, 86.0%, and 85.7%, respectively;
30-day mortality was 2.2% in quartile I, 3.2% in quartile
II, and 0% in quartiles III and IV (P  .03 for q I  II vs
q III  IV). Survival curves for quartiles II to IV were
statistically indistinguishable, with quartile II running
tangential to the two higher quartiles after the perioper-
ative period (Fig 1). Patients with the lowest GFR (quar-
tile I) did significantly worse than the other three quar-
tiles for the entire follow-up period (P  .0005).
According to the American Kidney Foundation criteria
(GFR 90), 83.3% of patients had abnormal renal func-
tion compared with 16.1% with abnormal creatinine (1.7
mg/dL) (P  .0002). For short-term mortality, signifi-
cant univariate predictors were age and GFR (Table I).
For long-term mortality, GFR was predictive (Fig 1), but
serum creatinine failed to meet statistical significance(Fig 2). In multivariable Cox proportional hazards re-
gression analysis, GFR was significant (P  .004), but
creatinine failed to reach significance (P  .11)
DISCUSSION
Renal insufficiency is a risk factor for mortality after
abdominal aortic aneurysm repair.7 Serum creatinine has
traditionally been used as a screening tool for renal dysfunc-
tion. The serum creatinine value can be influenced by a
variety of factors independent of GFR, including tubular
secretion and reabsorption, endogenous production, extra-
renal elimination, and medications.8 As a result, serum
creatinine values may be insensitive to mild or moderate
degrees of renal dysfunction.
One study of 2,781 patients in the community found
“a substantial prevalence of significantly abnormal renal
function among patients identified by laboratories as hav-
ing normal range serum creatinine.”9 The Third National
Health and Nutrition Examination Survey (NHANES III)
found that the prevalence of chronic kidney disease in the
United States population was 11% (19.2 million).10 Ad-
vanced age, diabetes mellitus, and hypertension were found
to be key predictors of chronic kidney disease. The study
concluded that, “chronic kidney disease is common and
warrants improved detection and classification using stan-
dardized criteria to improve outcomes.” In a recent study,
we found that the incidence of subclinical renal disease in a
patient population undergoing thoracoabdominal aortic
aneurysm repair was 70%.11 In other words, 70% of
patients with normal serum creatinine values had an abnor-
mal GFR.
Owing to the severe limitations in using serum creati-
nine as the only screening tool for renal dysfunction, a more
sensitive measure of GFR becomes necessary. The inherent
difficulties associated with measuring creatinine clearance
(GFR) with a 24-hour urine collection have resulted in the
Fig 1. Survival by glomerular filtration rate (GFR). At key time
points (0, 20, 40 months), the number of patients in each quartile
is listed above.development of a number of formulas for estimating GFR.
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creatinine clearance (GFR), Spinler et al12 found the Cock-
croft-Gault formula, which uses serum creatinine, age, sex,
and body weight, to be one of the most accurate. In the
NHANES III study, GFR was estimated using the Modifi-
cation of Diet in Renal Disease Study equation (MDRD)
and compared with the Cockcroft-Gault equation for cre-
atinine clearance.6 The Cockcroft-Gault equation estimates
closely matched theMDRD, but showed a “steeper decline
with age,” and were “lower in non-Hispanic blacks.” For
the purposes of this study, we selected the Cockcroft-Gault
equation for estimating GFR because of its simplicity,
accuracy, and availability of the required information in our
database.
Our study has demonstrated the sensitivity of GFR in
Table I. Thirty-day mortality
Variable No. patients (%) No. deaths (%
Overall 398 (100) 5 (1.3)
Age
48–68 107 (26.9) 0 (0.0)
69–73 97 (24.4) 0 (0.0)
74–78 106 (26.6) 1 (0.9)
79–91 88 (22.1) 4 (4.5)
Female 58 (14.6) 1 (1.7)
Male 340 (85.4) 4 (1.2)
GFR
60§
184 (48.7) 5 (2.7)
GFR
60§
194 (51.3) 0 (0.0)
Creatinine
1.7 64 (16.1) 2 (3.1)
1.7 334 (83.9) 3 (0.9)
*For dichotomous variables, the odds ratio represents a test against a refere
refers to the increase in odds associated with a one-unit increase in the variab
against the continuous variable.
†Reflects the units against which its companion odds ratio is computed. Co
‡Probability of type I statistical error (common P value).V alues without paren
logistic regression likelihood ratio P values.
§Glomerular filtration rate (GFR) could not be computed for 20 cases.
Fig 2. Survival by serum creatinine (Cr).detecting subclinical renal disease compared with serumcreatinine alone. Only 16.1% of patients had an abnormal
creatinine value, but 83.3% of patients had an abnormal
GFR (Fig 3).
Our results indicate that GFR is a more sensitive
predictor of perioperative and long-term mortality than
serum creatinine. Five patients reached the end point of
mortality at 30 days (Table I). Among them, serum
creatinine was not predictive (three patients had an
abnormal creatinine and two had normal creatinine);
however, GFR was predictive: all 5 patients had an
Odds ratio* 95% CI† P‡
1.18 1.01–1.35 .02
(.006)
1.47 0.16–13.42 .73
1
11.9 0.65–217.1 .03
1
3.56 0.58–21.74 .15
1
tegory whose referent odds ratio  1. For continuous data, the odds ratio
ue. Although continuous data are presented in quartiles, the odds ratios are
ce intervals (CI) are test-based.
s are Pearson 2 probabilities. Probability values in parentheses are univariate
Fig 3. Discrimination of glomerular filtration rate (GFR) vs that
of serum creatinine in detecting subclinical kidney disease. Only
16.1% of patients had an abnormal creatinine value, but 83.3% of
patients had an abnormal GFR.)
nce ca
le val
nfiden
theseabnormal GFR. The results for long-term mortality us-
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the predictive power of GFR.
The multivariable survival analysis summarized in Table
II clearly demonstrates that GFR is able to account for all of
the prognostic information available through creatinine
and to retain significant predictive power. The data dem-
onstrate that for every point increase in GFR, the mortality
hazard ratio was reduced by 2%.
CONCLUSION
This study suggests that the calculation of preoperative
GFR for patients undergoing EVAR has prognostic value.
This information will allow physicians to better tailor the
patient’s long-term medical care. Consideration should
also be given to the use of perioperative renal protection
techniques, alternative contrast agents, and imaging mo-
dalities. Finally, early recognition of postoperative renal
failure and a multimodality approach to its treatment may
improve results in high-risk patients.
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DrG. Patrick Clagett (Dallas, Tex). I have a simple question:
How do these people die? And is there a direct pathophysiologic
link between the abnormal GFR and their death, or is it simply a
marker? Because if it is just a marker, correcting renal function
preoperatively or takingmeasures to prevent deteriorationmay not
have any influence on the outcome.
DrAzizzadeh.Of the 5 patients who died in the perioperative
period, 4 died from cardiovascular complications. This is consis-
tent with abnormal GFR being a marker for generalized athero-
sclerotic disease.
In the calculation for GFR vs mortality over the long term,
patients in quartile II did significantly worse in the perioperative
period. I think, in this instance, the use of alternative imaging
technology and contrast agents may be helpful in decreasing the
postoperative renal morbidity secondary to contrast nephropathy
and possibly improving mortality.
Dr John Blebea (Philadelphia, Penn). What baseline serumhave undergone contrast studies, either subtraction angiography
or CT angios in the preoperative time period in addition to the
hydration associated with these studies, these could very signifi-
cantly affect your measured serum creatinine levels and also esti-
mated creatinine clearance. Did you utilize as the baseline creati-
nine the value before the CT or angiogram or that following these
studies? Could you go back and compare the results both ways and
see if it would have affected your results?
Dr Azizzadeh. Most of these patients underwent outpatient
procedures and this was done in the outpatient laboratory. We
used the preoperative serum creatinine. Usually there was no
angiography or immediate CT scan done prior to that measure-
ment.
Dr Kimberley Hansen (Winston-Salem, NC). In your
proportional hazards regression model, did you adjust for age?
Since age appears in the Cockcroft-Gault equation, the effect on
long-term survival may be an age effect and not a renal function
effect.
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not statistically significant when added to the other terms.
Dr Timothy Roush (Charlotte, NC). I have a question
regarding your protocol when you are doing your EVAR. Our
group published a paper in the New England Journal of Medicine
using a fairly simple bicarbonate protocol for renal protection last
year. In addition, we will usually use some form of nonionic
contrast.
My question concerns these mandatory follow-up studies and
their relationship to renal failure. A lot of these patients that we are
following are going to go through radiology for CT scans. At our
institution, 150 mL of ionic contrast will be given to patients with
a creatinine of up to 1.4.
I was curious what your thoughts are in relationship to this
entity of subclinical renal insufficiency, ongoing mortality, and
how that relates to some of the statistics that we’re seeing. Is there,
in fact, an ongoing decrement in renal function in patients that weare now clinically following who have had successful EVAR and
does that explain some of the numbers that we’re seeing with
decreased survival later on?
Dr Azizzadeh. I think renal failure continues to remain a risk
factor for mortality. Consideration should be given to the use of
alternative contrast agents and imaging modalities.
Dr Michele Carmo (Rochester, Minn). You showed in
your multivariable analysis that creatinine is not statistically
significant, and I was wondering if it was significant in the
univariate analysis?
Did you check for colinearity existing between the GFR and
creatinine in the multivariable analysis? We know that GFR de-
pends on creatinine and they may travel together.
DrAzizzadeh.The creatinine failed to reach significance in all
the statistical analysis that was performed both in the 30-day and
long-term mortality as well as the multivariable analysis. None of
our regression diagnostics showed important colinearity.
